Details of the Drug

General Information of Drug (ID: DMTXR77)

Drug Name

GSK-2302025A

Synonyms

PRAME ASCI (melanoma), GSK; Recombinant preferentially expressed antigen of melanoma immunotherapeutic vaccine (melanoma), GlaxoSmithKline

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01149343) Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer. U.S. National Institutes of Health.